Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
247.99
+58.02 (30.54%)
At close: Dec 5, 2025, 4:00 PM EST
251.25
+3.26 (1.31%)
After-hours: Dec 5, 2025, 7:59 PM EST
PRAX Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for PRAX stock have an average target of 239.62, with a low estimate of 73 and a high estimate of 424. The average target predicts a decrease of -3.38% from the current stock price of 247.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 8 | 9 | 9 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Sell Maintains $77 → $83 | Sell | Maintains | $77 → $83 | -66.53% | Dec 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $258 → $340 | Strong Buy | Maintains | $258 → $340 | +37.10% | Dec 5, 2025 |
| Needham | Needham | Strong Buy Maintains $250 → $304 | Strong Buy | Maintains | $250 → $304 | +22.59% | Dec 5, 2025 |
| Needham | Needham | Strong Buy Reiterates $250 | Strong Buy | Reiterates | $250 | +0.81% | Dec 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $258 | Strong Buy | Reiterates | $258 | +4.04% | Nov 25, 2025 |
Financial Forecast
Revenue This Year
306.00K
from 8.55M
Decreased by -96.42%
Revenue Next Year
81.60K
from 306.00K
Decreased by -73.33%
EPS This Year
-13.31
from -10.21
EPS Next Year
-13.21
from -13.31
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.2M | 630,000 | ||||
| Avg | 306,000 | 81,600 | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -63.2% | 105.9% | ||||
| Avg | -96.4% | -73.3% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -12.57 | -5.91 | ||||
| Avg | -13.31 | -13.21 | ||||
| Low | -14.00 | -20.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.